Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06969950 · ClinicalTrials.gov registry record · Phase 2

Evaluating an Intervention for Physician Burnout

A Phase 2 study of Physician Burnout, sponsored by Brown University.

Recruiting
Registry status
Phase 2
Development phase
100
Enrollment target
1
Study location

NCT06969950: Recruiting Phase 2 study of Physician Burnout, sponsored by Brown University.

NCT06969950 is a Phase 2 study of Physician Burnout that is actively recruiting participants, run by Brown University. The registered enrollment target is 100 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06969950, a Phase 2 study of Physician Burnout, is actively recruiting participants, sponsored by Brown University.

RECRUITING
Registry status
Phase 2
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The goals of this randomized controlled trial are 1) to test the efficacy of an app-based program in reducing physician burnout vs. no app (control) in 100 physicians; 2) to explore the role of an online live training to augment outcomes and develop an ongoing and sustainable support community with a subsample of physicians.

Primary Outcome

Maslach Burnout Inventory (MBI) cynicism. The MBI is a validated 22-item self-report measure of risk of burnout. Items are rated on a 7-point Likert scale ranging from 0 (never) to 6 (every day). The investigators will use only one single-item measure of cynicism that was included from the Maslach Burnout Inventory (MBI)-based on the research of West et al., 2009.

Conditions Studied

Interventions

  • OTHER App-Delivered Mindfulness Training (MT).
  • OTHER Online Virtual Training

Study Locations (1)

Rhode Island

  • Brown University - Providence

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-02-12
Est. Completion 2026-02-27
Phase Phase 2
Brown University

231 total trials

What NCT06969950 shows while recruiting

NCT06969950 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (25% lower).

The record links to 1 condition, with Physician Burnout appearing as the primary indexed condition, and to 2 interventions - of which App-Delivered Mindfulness Training (MT). is the first listed.

NCT06969950 reports a single indexed study location in Rhode Island.

Frequently Asked Questions

What is clinical trial NCT06969950 about?

NCT06969950 is a clinical study titled "Evaluating an Intervention for Physician Burnout". The goals of this randomized controlled trial are 1) to test the efficacy of an app-based program in reducing physician burnout vs. no app (control) in 100 physicians; 2) to explore the role of an online live training to augment outcomes and develop an ongoing and sustainable support community with ...

What is the current status of trial NCT06969950?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2025-02-12. Estimated completion is 2026-02-27.

What conditions does trial NCT06969950 study?

This clinical trial studies the following conditions: Physician Burnout.

What interventions are being tested in trial NCT06969950?

The interventions under investigation include: App-Delivered Mindfulness Training (MT). (OTHER), Online Virtual Training (OTHER).

Who is sponsoring clinical trial NCT06969950?

This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06969950 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT06969950's enrollment target sits among peer trials

100 672nd of 2000 higher than 1,263 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06969950, the US trial registry maintained by the National Library of Medicine. NCT06969950 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.